Clinical Trial

Decoupling Immunotherapy Toxicity and Cancer Response

Name: Decoupling Immunotherapy Toxicity and Cancer Response — clinical trial record (NCT07382752)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study is a novel evaluation of cardiotoxicity after ICI therapy based on traditional CV risk factors with the addition of metabolomic profiles, epigenetic aging, and CHIP. It is not an extension of previous work in ICI therapy.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-26.

Trial Details

NCT Number	NCT07382752
Lead Sponsor	M.D. Anderson Cancer Center
Conditions	Tumor, Cardiovascular
Enrollment	1,200 participants
Start Date	2026-01-09
Primary Completion	2028-06-30 (estimated)
Study Completion	2030-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-16